Redmile as of Sept. 30, 2011
Portfolio Holdings for Redmile
Redmile holds 30 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Onyx Pharmaceuticals | 9.0 | $19M | 620k | 30.01 | |
| Ariad Pharmaceuticals | 7.5 | $15M | 1.7M | 8.79 | |
| CareFusion Corporation | 6.8 | $14M | 580k | 23.95 | |
| Gilead Sciences (GILD) | 6.8 | $14M | 358k | 38.80 | |
| Sequenom | 6.1 | $13M | 2.5M | 5.09 | |
| United Therapeutics Corporation (UTHR) | 5.7 | $12M | 311k | 37.49 | |
| Align Technology (ALGN) | 5.6 | $12M | 765k | 15.17 | |
| Express Scripts | 5.2 | $11M | 287k | 37.07 | |
| Dynavax Technologies Corporation | 4.8 | $9.9M | 5.3M | 1.86 | |
| Auxilium Pharmaceuticals | 4.1 | $8.4M | 561k | 14.99 | |
| Baxter International (BAX) | 3.8 | $7.8M | 140k | 56.14 | |
| Medtronic | 3.2 | $6.6M | 200k | 33.24 | |
| ArthroCare Corporation | 3.2 | $6.6M | 230k | 28.77 | |
| CONMED Corporation (CNMD) | 3.2 | $6.5M | 284k | 23.01 | |
| BioSpecifics Technologies | 3.1 | $6.5M | 402k | 16.14 | |
| Incyte Corporation (INCY) | 3.1 | $6.4M | 455k | 13.97 | |
| Nektar Therapeutics | 2.8 | $5.7M | 1.2M | 4.85 | |
| Cutera | 2.6 | $5.3M | 747k | 7.12 | |
| Trius Therapeutics | 2.5 | $5.2M | 819k | 6.30 | |
| NPS Pharmaceuticals | 2.4 | $4.9M | 757k | 6.51 | |
| GTx | 2.0 | $4.1M | 1.2M | 3.35 | |
| Medivation | 1.8 | $3.8M | 221k | 16.98 | |
| Anthera Pharmaceuticals | 1.7 | $3.6M | 747k | 4.77 | |
| TranS1 (TSON) | 0.9 | $1.8M | 600k | 3.00 | |
| LeMaitre Vascular (LMAT) | 0.9 | $1.8M | 286k | 6.26 | |
| Synta Pharmaceuticals | 0.4 | $893k | 275k | 3.25 | |
| Cyclacel Pharmaceuticals | 0.4 | $780k | 1.8M | 0.44 | |
| AVI BioPharma | 0.3 | $580k | 518k | 1.12 | |
| Amicus Therapeutics (FOLD) | 0.1 | $122k | 32k | 3.82 | |
| Savient Pharmaceuticals | 0.0 | $71k | 17k | 4.08 |
